PharmaShots | Incisive News in 3 Shots

Subscribe Now

tumors

Chi-Med Initiates Rolling Submission of NDA to the US FDA of Surufatinib to Treat Advanced Neuroendocrine Tumors

Chi-Med Initiates Rolling Submission of NDA to the US FDA of Surufatinib to Treat Advanced Neuroendocrine Tumors

December 30, 2020

Roche to Present its Oncology Portfolio at the ESMO Virtual Congress 2020

Roche to Present its Oncology Portfolio at the ESMO Virtual Congress 2020

September 17, 2020

Roche's Polatuzumab Vedotin as Combination Therapy & Entrectinib Receives FDA's Priority Review for r/r Diffuse DLBCL & NTRK Fusion-Positive Solid Tumors

Roche's Polatuzumab Vedotin as Combination Therapy & Entrectinib Receives FDA's Priority Review for r/r Diffuse DLBCL & NT...

February 19, 2019

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us